These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8725734

  • 1. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass.
    Wahba A, Black G, Koksch M, Rothe G, Preuner J, Schmitz G, Birnbaum DE.
    Thromb Haemost; 1996 May; 75(5):844-8. PubMed ID: 8725734
    [Abstract] [Full Text] [Related]

  • 2. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R, Golański J, Chizyński K, Iwaszkiewicz A, Zasłonka J, Pietrucha T, Chrul S, Watała C.
    Med Sci Monit; 2000 May; 6(4):722-8. PubMed ID: 11208399
    [Abstract] [Full Text] [Related]

  • 3. Platelet dysfunction after normothermic cardiopulmonary bypass in children: effect of high-dose aprotinin.
    Flaujac C, Pouard P, Boutouyrie P, Emmerich J, Bachelot-Loza C, Lasne D.
    Thromb Haemost; 2007 Aug; 98(2):385-91. PubMed ID: 17721621
    [Abstract] [Full Text] [Related]

  • 4. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
    van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CR.
    J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
    [Abstract] [Full Text] [Related]

  • 5. Platelet function during cardiopulmonary bypass not changed by two different doses of aprotinin.
    Santamaría A, Mateo J, Muñíz-Díaz E, Oliver A, Murillo J, Litvan H, Souto JC, Fontcuberta J.
    Haematologica; 2000 Apr; 85(4):381-5. PubMed ID: 10756363
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study.
    Mohr R, Goor DA, Lusky A, Lavee J.
    Circulation; 1992 Nov; 86(5 Suppl):II405-9. PubMed ID: 1385010
    [Abstract] [Full Text] [Related]

  • 10. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A, Wildhirt SM, Wang S, Koshal A, Radomski MW.
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [Abstract] [Full Text] [Related]

  • 11. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
    Dietrich W, Mössinger H, Spannagl M, Jochum M, Wendt P, Barankay A, Meisner H, Richter JA.
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
    [Abstract] [Full Text] [Related]

  • 12. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K, Zimmermann T, Kampe S, Kasper SM, Weber HJ, Geissler HJ, Mehlhorn U.
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [Abstract] [Full Text] [Related]

  • 13. [Effect of aprotinin on selected parameters of coagulation and drainage blood loss after cardiac operations in patients without coagulation disorders].
    Hirnle T, Stachurski A, Goździk W, Pelczar M, Wachnik J, Hirnle G, Milczarska J, Kustrzycki W.
    Pol Merkur Lekarski; 2006 May; 20(119):543-6. PubMed ID: 16875158
    [Abstract] [Full Text] [Related]

  • 14. Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
    Kondo N, Suzuki Y, Wakayama F, Tamai Y, Ji K, Fukui K, Fukuda I.
    Ann Thorac Surg; 2005 Jul; 80(1):251-7. PubMed ID: 15975376
    [Abstract] [Full Text] [Related]

  • 15. Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin.
    Basora M, Gomar C, Escolar G, Pacheco M, Fita G, Rodriguez E, Ordinas A.
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):382-7. PubMed ID: 10468248
    [Abstract] [Full Text] [Related]

  • 16. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A, Hiippala S, Vahtera E, Rasi V, Salmenperä M.
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A study of platelet activation during human cardiopulmonary bypass and the effect of S-nitrosoglutathione.
    Langford EJ, Parfitt A, de Belder AJ, Marrinan MT, Martin JF.
    Thromb Haemost; 1997 Dec; 78(6):1516-9. PubMed ID: 9423805
    [Abstract] [Full Text] [Related]

  • 19. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB, Lemke J, Lange M, Rastan A, Mohr FW.
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [Abstract] [Full Text] [Related]

  • 20. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Greilich PE, Jessen ME, Satyanarayana N, Whitten CW, Nuttall GA, Beckham JM, Wall MH, Butterworth JF.
    Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.